Nivolumab in AML in Remission at High Risk for Relapse

Clinical trial NCT02532231 · COMPLETED

Trial details

NCT number: NCT02532231
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Adult Acute Myeloid Leukemia in Remission Blasts Under 10 Percent of Bone Marrow Nucleated Cells Therapy-Related Myeloid Neoplasm

Start date: 2015-10-19
Primary completion: 2023-08-08
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.